HPLC enantiomer separation of a chiral 1,4-dihydropyridine monocarboxylic acid.
An enantioselective anion exchanger based on tert-butylcarbamoylquinine as chiral selector and thiol-modified silica as chromatographic support was applied for the enantiomer separation of the shortacting calcium antagonist clevidipine after its hydrolysis to methyl 4-(2',3'-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate. This hydrolyzed derivative of clevidipine is the primary metabolite and precursor of the parent drug. Method development included the steps of optimization of the composition of the mobile phase (pH, type and content of organic modifier, polar organic mode), screening of various structural analogs of above mentioned CSP, and evaluation of the effect of the flow rate. These detailed studies gave insight into the operational mode of the CSP, which is basically an enantioselective anion exchange mechanism. The polar organic mode turned out to be advantageous with regard to enantioselectivity and resolution. The optimized method makes use of an eluent composed of 0.125% acetic acid in acetonitrile with flow rate of 1 ml/min at a constant temperature of 25 degrees C, and allows the separation of the both enantiomers with enantioselectivity alpha of 1.25 and a resolution RS of 3.0 within 10 min. On the above mentioned quinine carbamate phase the (R)-enantiomer is stronger retained, while a change to the corresponding quinidine carbamate CSP allows the reversal of the elution order.
Lämmerhofer
Michael
M
Christian Doppler Laboratory for Molecular Recognition Materials, Institute of Analytical Chemistry, University of Vienna, Währingerstrasse 38, A-1090 Vienna, Austria.
Gyllenhaal
Olle
O
Lindner
Wolfgang
W
D002264:Carboxylic Acids / Q000032:analysis* / Q000737:chemistry; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D004095:Dihydropyridines / Q000032:analysis* / Q000737:chemistry; D013237:Stereoisomerism
D002264:Carboxylic Acids; D004095:Dihydropyridines; C038806:1,4-dihydropyridine